AU2002230781A1 - Pharmaceutical uses and synthesis of benzobicyclooctanes - Google Patents

Pharmaceutical uses and synthesis of benzobicyclooctanes

Info

Publication number
AU2002230781A1
AU2002230781A1 AU2002230781A AU2002230781A AU2002230781A1 AU 2002230781 A1 AU2002230781 A1 AU 2002230781A1 AU 2002230781 A AU2002230781 A AU 2002230781A AU 2002230781 A AU2002230781 A AU 2002230781A AU 2002230781 A1 AU2002230781 A1 AU 2002230781A1
Authority
AU
Australia
Prior art keywords
benzobicyclooctanes
synthesis
pharmaceutical uses
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002230781A
Inventor
Ted A. Baughman
Ihab Darwish
J. Jeffry Howbert
Randy W. Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Celltech R&D Inc
Original Assignee
Celltech R&D Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech R&D Inc filed Critical Celltech R&D Inc
Publication of AU2002230781A1 publication Critical patent/AU2002230781A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic System
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/0803Compounds with Si-C or Si-Si linkages
    • C07F7/081Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
AU2002230781A 2000-12-22 2001-12-11 Pharmaceutical uses and synthesis of benzobicyclooctanes Abandoned AU2002230781A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US25753200P 2000-12-22 2000-12-22
US60/257,532 2000-12-22
PCT/US2001/047993 WO2002051851A2 (en) 2000-12-22 2001-12-11 Pharmaceutical uses and synthesis of benzobicyclooctanes

Publications (1)

Publication Number Publication Date
AU2002230781A1 true AU2002230781A1 (en) 2002-07-08

Family

ID=22976679

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002230781A Abandoned AU2002230781A1 (en) 2000-12-22 2001-12-11 Pharmaceutical uses and synthesis of benzobicyclooctanes

Country Status (2)

Country Link
AU (1) AU2002230781A1 (en)
WO (1) WO2002051851A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7253283B2 (en) 2004-01-16 2007-08-07 Bristol-Myers Squibb Company Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7605264B2 (en) 2004-01-16 2009-10-20 Bristol-Myers Squibb Company Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7625921B2 (en) 2004-01-16 2009-12-01 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7326728B2 (en) 2004-01-16 2008-02-05 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κβ activity and use thereof
US7273881B2 (en) 2004-01-16 2007-09-25 Bristol-Myers Squibb Company Modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7569689B2 (en) 2004-01-16 2009-08-04 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7642273B2 (en) 2005-01-13 2010-01-05 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7411071B2 (en) 2005-01-13 2008-08-12 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7361654B2 (en) 2005-01-13 2008-04-22 Bristol-Myers Squibb Co. Substituted heteroaryl amide modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
US7317024B2 (en) 2005-01-13 2008-01-08 Bristol-Myers Squibb Co. Heterocyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof

Also Published As

Publication number Publication date
WO2002051851A3 (en) 2003-01-23
WO2002051851A2 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
AU2001277754A1 (en) Proline derivatives and use thereof as drugs
AU2001235691A1 (en) Use of paullone derivatives for making medicines
AU2001269508A1 (en) Drugs or cosmetics
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2002351764A1 (en) Flavonoid compounds and their pharmaceutical uses
AU2002346548A1 (en) Regioisomerically pure oxochlorins and methods of synthesis
AU2002213422A1 (en) Synthesis of 2-hydroxymethylglutamic acid and congeners thereof
AU2002256108A1 (en) Synthesis and use of glycodendrimer reagents
AU2001297611A1 (en) Pharmaceutical uses and synthesis of diketopiperazines
AU2002230781A1 (en) Pharmaceutical uses and synthesis of benzobicyclooctanes
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU5587200A (en) Synthesis of substituted amidines
AU2001264863A1 (en) Preparation of fagopyritols and uses therefor
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001265280A1 (en) Preparation of 2-hydroxy-5-oxoproline and analogs thereof
AUPR197000A0 (en) Synthesis of small particles
AU4876701A (en) Peptide derivatives and medicinal compositions
AU2002212327A1 (en) Pharmaceutical preparation comprised of milk-thistle and terpenes
AU4450100A (en) 225Ac-heha and related compounds, methods of synthesis and methods of use
AU4543500A (en) Pharmaceutical compositions and uses
AU2001262928A1 (en) Pharmaceutical compositions and their use
AU2002308105A1 (en) Benzoaxathiepin derivatives and their use as medicines
AU4940800A (en) Polyketides and their synthesis
AU2002227333A1 (en) Pharmaceutical uses and synthesis of nicotinanilide-n-oxides

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase